|
Volumn 52, Issue 2, 2005, Pages 90-95
|
Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma;Budesonida nasal más zafirlukast vs budesonida nasal más loratadina- pseudoefedrina en el control de los síntomas de la rinitis y el asma.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIALLERGIC AGENT;
ANTIASTHMATIC AGENT;
BUDESONIDE;
EPHEDRINE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LORATADINE;
TOLUENESULFONIC ACID DERIVATIVE;
ZAFIRLUKAST;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
FEMALE;
HAY FEVER;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PERENNIAL RHINITIS;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT ALLERGY;
TREATMENT OUTCOME;
ADMINISTRATION, INTRANASAL;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADRENERGIC AGENTS;
ADULT;
ANTI-ALLERGIC AGENTS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BUDESONIDE;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
EPHEDRINE;
FEMALE;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
LORATADINE;
MALE;
MIDDLE AGED;
RESPIRATORY HYPERSENSITIVITY;
RHINITIS, ALLERGIC, PERENNIAL;
RHINITIS, ALLERGIC, SEASONAL;
TOSYL COMPOUNDS;
TREATMENT OUTCOME;
|
EID: 27144533631
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|